About: Use of Transgenic Animals in Biotechnology: Prospects and Problems

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Use of Transgenic Animals in Biotechnology: Prospects and Problems Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Use of Transgenic Animals in Biotechnology: Prospects and Problems
Creator	Deykin, A Georgiev, P Khodarovich, Yu Maksimenko, O
Source	PMC
abstract	During the past two decades, there have been numerous attempts at using animals in order to produce recombinant human proteins and monoclonal antibodies. However, it is only recently that the first two therapeutic agents isolated from the milk of transgenic animals, C1 inhibitor (Ruconest) and antithrombin (ATryn), appeared on the market. This inspires hope that a considerable number of new recombinant proteins created using such technology could become available for practical use in the near future. In this review, the methods applied to produce transgenic animals are described and the advantages and drawbacks related to their use for producing recombinant human proteins and monoclonal antibodies are discussed.
has issue date	2013-01-01(xsd:dateTime)
bibo:pmid	23556129
has license	cc-by
sha1sum (hex)	7722e2866e2b7849cc2f3175430a1048d97b71d9
resource representing a document's title	Use of Transgenic Animals in Biotechnology: Prospects and Problems
has PubMed Central identifier	PMC3612824
has PubMed identifier	23556129
schema:publication	Acta Naturae
resource representing a document's body	covid:7722e2866e2b7849cc2f3175430a1048d97b71d9#body_text
is schema:about of	named entity 'RHA' named entity 'NUCLEAR TRANSFER' named entity 'FDA' named entity 'RECOMBINANT PROTEINS' named entity 'USE OF' named entity 'recombinant protein' named entity 'Problems' named entity 'Food' named entity 'untranslated region' named entity 'EVALUATION' named entity 'BIOTECHNOLOGY' named entity 'MEDICINES' named entity 'TECHNOLOGY' named entity 'INTRANUCLEAR' named entity 'EMBRYONIC STEM CELLS' named entity 'OVARY' named entity 'RELATED' named entity 'PRODUCING' named entity 'TO PRODUCE' named entity 'METHODS' named entity 'RECOMBINANT' named entity 'HUMAN' named entity 'THERAPEUTIC AGENTS' named entity 'HAVE' named entity 'REVIEW' named entity 'USING' named entity 'MONOCLONAL ANTIBODIES' named entity 'EMEA' named entity 'CHINESE HAMSTER' named entity 'PRODUCTION' named entity 'ABBREVIATIONS' named entity 'EUROPEAN' named entity 'RECOMBINANT PROTEINS' named entity 'NEW' named entity 'RECENTLY' named entity 'MONOCLONAL ANTIBODIES' named entity 'AGENCY' named entity 'HUMAN ALBUMIN' named entity 'ES CELLS' named entity 'UTR' named entity 'MILK PROTEIN' named entity 'TRANSGENIC ANIMAL' named entity 'CHO CELLS' named entity 'RECOMBINANT' named entity 'UNITED STATES FOOD AND DRUG ADMINISTRATION' named entity 'UNTRANSLATED REGION' named entity 'RECOMBINANT PROTEIN' named entity 'A GENE' named entity 'DRUGS' named entity 'PAST' named entity 'CONSIDERABLE' named entity 'FUTURE' named entity 'APPLIED' named entity 'ORDER' named entity 'HOPE' named entity 'MILK' named entity 'ANIMALS' named entity 'ANTITHROMBIN' named entity 'NEAR' named entity 'ISOLATED' named entity 'THEIR' named entity 'C1 INHIBITOR' named entity 'DESCRIBED' named entity 'MARKET' named entity 'CREATED' named entity 'NUMBER OF' named entity 'TRANSGENIC ANIMALS' named entity 'MAB' named entity 'PROBLEMS' named entity 'THERAPEUTIC' named entity 'BIOREACTOR' named entity 'NUMEROUS' named entity 'PROTEIN PRODUCTION' named entity 'CELLS' named entity 'AVAILABLE' named entity 'HUMAN PROTEINS' named entity 'USE' named entity 'MICROINJECTION ' named entity 'DNA' named entity 'TRANSGENIC ANIMALS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software